OmniActive Health Technologies (OmniActive) has announced the launch of its highly anticipated Curcuwin Ultra+, which is the latest addition to the company’s branded, highly bioavailable curcumin portfolio
“It’s no news that curcumin is still wildly popular with consumers, and as their demands evolved, we saw that there were multiple gaps arising in the market,” said Sayantan Bhattacharya, Senior Director, Category Manager who oversees OmniActive’s branded curcumin products.
“Curcuwin Ultra+ addresses several of these challenges in a single, convenient ingredient.”
Curcuwin Ultra+ is a clinically studied, natural solution to help support joint and general health benefits for on-the-go lifestyles by delivering
Curcuwin Ultra+ is formulated using a unique, specialised process that incorporates bioenhancers to better protect and deliver more curcuminoids than standard curcumin.
In a clinical study, it was shown to be 144 times more bioavailable compared with standard curcumin. In fact, one capsule containing 250/500 mg of Curcuwin Ultra+ is equal to 30 capsules of standard curcumin/turmeric powder.
It is also absorbed 40% faster than standard curcumin. And because it is made using Ultrasol, the same foundational technology, as its predecessor, it also comes with the clinically supported heart health and sports nutrition benefits as the original Curcuwin.
“This product aims at disrupting how brands formulate with curcumin in an era where consumers are constantly looking at convenient solutions that can deliver more for less,” said Isabel Lucas, Director of Product Launch and Marketing Excellence, OmniActive.
“We believe people will be highly interested in Curcuwin Ultra+ because of its clinically demonstrated bioavailability and that it addresses consumer needs in the joint health, sports nutrition and active wellness markets.”
Curcuwin Ultra+ will be commercially available in the first half of 2022.